PHARMA FUSION Trademark

Trademark Overview


On Wednesday, October 15, 2025, a trademark application was filed for PHARMA FUSION with the United States Patent and Trademark Office. The USPTO has given the PHARMA FUSION trademark a serial number of 99444231. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, March 24, 2026. This trademark is owned by Pharma Fusion LLC. The PHARMA FUSION trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Business consulting services in the field of healthcare, featuring AI-driven automation tools designed to optimize patient recovery outcomes, reduce hospital and clinical visits, and support accurate medication recommendations; providing data analytics and predictive modeling services for healthcare providers to enhance treatment efficiency and patient engagement; business management and advisory services for medical practices integrating artificial intelligence technologies to streamline care delivery and improve operational performance.

Prescribed medications through the use of AI-driven automation tools designed to optimize patient recovery outcomes, reduce hospital and clinical visits, and support accurate medication recommendations, namely, providing prescribed medications to individuals using home infusion therapy, that is, the intravenous or subcutaneous administration of drugs or biologicals to an individual at home or at other sites outside of medical facilities.

Pharmacy services, namely, home infusion specialty pharmacy services to provide medically necessary infusion therapies to patients in their homes or other sites outside of medical facilities, and pharmacy services to health care providers to assist in prescribing medically appropriate and cost-effective treatment to patients; Prescribed medications through the use of AI-driven automation tools designed to optimize patient recovery outcomes, reduce hospital and clinical visits, and support accurate medication recommendations, namely, providing prescribed medications to individuals using home infusion therapy, that is, the intravenous or subcutaneous administration of drugs or biologicals being home health care services to an individual at home or at other sites outside of medical facilities.
pharma fusion

General Information


Serial Number99444231
Word MarkPHARMA FUSION
Filing DateWednesday, October 15, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, March 24, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesBusiness consulting services in the field of healthcare, featuring AI-driven automation tools designed to optimize patient recovery outcomes, reduce hospital and clinical visits, and support accurate medication recommendations; providing data analytics and predictive modeling services for healthcare providers to enhance treatment efficiency and patient engagement; business management and advisory services for medical practices integrating artificial intelligence technologies to streamline care delivery and improve operational performance.
Goods and ServicesPrescribed medications through the use of AI-driven automation tools designed to optimize patient recovery outcomes, reduce hospital and clinical visits, and support accurate medication recommendations, namely, providing prescribed medications to individuals using home infusion therapy, that is, the intravenous or subcutaneous administration of drugs or biologicals to an individual at home or at other sites outside of medical facilities.
Goods and ServicesPharmacy services, namely, home infusion specialty pharmacy services to provide medically necessary infusion therapies to patients in their homes or other sites outside of medical facilities, and pharmacy services to health care providers to assist in prescribing medically appropriate and cost-effective treatment to patients; Prescribed medications through the use of AI-driven automation tools designed to optimize patient recovery outcomes, reduce hospital and clinical visits, and support accurate medication recommendations, namely, providing prescribed medications to individuals using home infusion therapy, that is, the intravenous or subcutaneous administration of drugs or biologicals being home health care services to an individual at home or at other sites outside of medical facilities.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 15, 2025
Primary Code005
First Use Anywhere DateMonday, July 1, 2024
First Use In Commerce DateMonday, July 1, 2024

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, October 15, 2025
Primary Code035
First Use Anywhere DateMonday, July 1, 2024
First Use In Commerce DateMonday, July 1, 2024

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 15, 2025
Primary Code044
First Use Anywhere DateMonday, July 1, 2024
First Use In Commerce DateMonday, July 1, 2024

Trademark Owner History


Party NamePharma Fusion LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLake Charles, LA 70601
US

Trademark Events


Event DateEvent Description
Wednesday, October 15, 2025NEW APPLICATION ENTERED
Wednesday, October 15, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, February 11, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 3, 2026ASSIGNED TO EXAMINER
Thursday, March 12, 2026NON-FINAL ACTION WRITTEN
Thursday, March 12, 2026NON-FINAL ACTION E-MAILED
Thursday, March 12, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 24, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 24, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 24, 2026TEAS/EMAIL CORRESPONDENCE ENTERED